The annual audit held during the second week of November has confirmed and renewed 4bases’ ISO 13485 certification, absolutely essential for the production and commercialization

12 ways to reduce cancer risks[1] #1 Do not smoke. Do not use any form of tobacco. #2 Make your home smoke free. Support smoke-free

Making a difference for the patients – 4bases’ paper of the month “Enabling Technologies for Personalized and Precision Medicine”[1] Whereas last month we have read

We always hear about the highly celebrated Precision Medicine, but what is this in reality? An answer might be “the possibility to adopt a very

4bases proudly announces a new important step in its development plan. Thanks to an exclusive commercial partnership with the ILC Group, 4bases’ products and services

Manno, March 31, 2020 4bases SA, a swiss-based company specialized in the development, production and commercialization of reagent kits for NGS (New Generation Sequencing) is

Custom panel – developed on-demand for your specific RUO or CE-IVD specific applications.

To make your choice easier and faster 4bases’ company and product information are gathered in the new brochure

Manno, December 3st, 2019. 4bases SA, a Swiss-based company specialized in the development, production, and commercialization of reagent kits and gene assays for clinical NGS,

Since the end of May 2019, around 40% of patients with HR+/HER2- breast cancer can count on a new drug developed by Novartis and approved